{"product_id":"rad140-1gr","title":"RAD-140 1g","description":"\u003ch3\u003e\n\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                    \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN \u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eCONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp data-start=\"53\" data-end=\"576\"\u003e\u003cstrong\u003eRAD-140 \u003c\/strong\u003e(testolone) is an oral, non-steroidal \u003cstrong data-start=\"132\" data-end=\"180\"\u003eselective androgen receptor modulator (SARM)\u003c\/strong\u003e engineered to deliver \u003cstrong data-start=\"203\" data-end=\"242\"\u003eanabolic effects in muscle and bone\u003c\/strong\u003e with comparatively \u003cstrong data-start=\"262\" data-end=\"299\"\u003eless stimulation of prostate\/skin\u003c\/strong\u003e than testosterone. It binds the \u003cstrong data-start=\"332\" data-end=\"358\"\u003eandrogen receptor (AR)\u003c\/strong\u003e, recruits muscle\/bone-biased co-activators, and—unlike testosterone—\u003cstrong data-start=\"427\" data-end=\"462\"\u003edoes not aromatize to estradiol\u003c\/strong\u003e or undergo 5-α reduction. RAD-140 is \u003cstrong data-start=\"500\" data-end=\"524\"\u003enot FDA\/EMA-approved\u003c\/strong\u003e and is \u003cstrong data-start=\"532\" data-end=\"554\"\u003eprohibited by WADA\u003c\/strong\u003e as an anabolic agent.\u003c\/p\u003e\n\u003chr data-start=\"578\" data-end=\"581\"\u003e\n\u003ch3 data-start=\"583\" data-end=\"641\"\u003eAdditional Benefits of RAD-140 Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"643\" data-end=\"2900\" class=\"w-fit min-w-(--thread-content-width)\" style=\"width: 100%;\"\u003e\n\u003cthead data-start=\"643\" data-end=\"671\"\u003e\n\u003ctr data-start=\"643\" data-end=\"671\"\u003e\n\u003cth data-start=\"643\" data-end=\"653\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-start=\"653\" data-end=\"671\" data-col-size=\"xl\" style=\"width: 71.2996%;\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"682\" data-end=\"2900\"\u003e\n\u003ctr data-start=\"682\" data-end=\"1026\"\u003e\n\u003ctd data-start=\"682\" data-end=\"751\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"684\" data-end=\"750\"\u003e1 Potent lean-mass accrual (preclinical → early translational)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"751\" data-end=\"1026\" data-col-size=\"xl\" style=\"width: 71.2996%;\"\u003eIn castrate\/ovariectomy and diet-induced models, RAD-140 \u003cstrong data-start=\"810\" data-end=\"854\"\u003eincreases fat-free mass and myofiber CSA\u003c\/strong\u003e with \u003cstrong data-start=\"860\" data-end=\"892\"\u003elimited prostate stimulation\u003c\/strong\u003e—per-mg potency among the higher in the SARM class. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Pharmacology \u0026amp; Experimental Therapeutics; FASEB Journal\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1027\" data-end=\"1274\"\u003e\n\u003ctd data-start=\"1027\" data-end=\"1055\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"1029\" data-end=\"1054\"\u003e2 Strength \u0026amp; function\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"1055\" data-end=\"1274\" style=\"width: 71.2996%;\"\u003eImproves \u003cstrong data-start=\"1066\" data-end=\"1133\"\u003especific force, grip strength, and stair\/peak torque surrogates\u003c\/strong\u003e in animal\/bench models; human functional datasets remain limited. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Medicine \u0026amp; Science in Sports \u0026amp; Exercise; AJP–Endocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1275\" data-end=\"1489\"\u003e\n\u003ctd data-start=\"1275\" data-end=\"1305\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"1277\" data-end=\"1304\"\u003e3 Bone-anabolic effects\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"1305\" data-end=\"1489\" style=\"width: 71.2996%;\"\u003eRaises \u003cstrong data-start=\"1314\" data-end=\"1321\"\u003eBMD\u003c\/strong\u003e, enhances \u003cstrong data-start=\"1332\" data-end=\"1359\"\u003etrabecular architecture\u003c\/strong\u003e, and improves \u003cstrong data-start=\"1374\" data-end=\"1400\"\u003ebiomechanical strength\u003c\/strong\u003e with modest prostate changes. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Bone and Mineral Research; Bone\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1490\" data-end=\"1712\"\u003e\n\u003ctd data-start=\"1490\" data-end=\"1526\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"1492\" data-end=\"1525\"\u003e4 Anti-catabolic under stress\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"1526\" data-end=\"1712\" style=\"width: 71.2996%;\"\u003e\n\u003cstrong data-start=\"1528\" data-end=\"1567\"\u003eDown-shifts atrogenes (MAFbx\/MuRF1)\u003c\/strong\u003e and preserves CSA during \u003cstrong data-start=\"1593\" data-end=\"1632\"\u003eglucocorticoids, disuse, or illness\u003c\/strong\u003e in preclinical studies. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Endocrine Reviews; Molecular Metabolism\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1713\" data-end=\"1937\"\u003e\n\u003ctd data-start=\"1713\" data-end=\"1755\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"1715\" data-end=\"1754\"\u003e5 Body-composition “repartitioning”\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1755\" data-end=\"1937\" data-col-size=\"xl\" style=\"width: 71.2996%;\"\u003eIn obese models, \u003cstrong data-start=\"1774\" data-end=\"1794\"\u003ereduces fat mass\u003c\/strong\u003e while preserving or increasing lean tissue—largely via AR-mTOR activation and improved oxidative programs. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Obesity; Metabolism\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1938\" data-end=\"2204\"\u003e\n\u003ctd data-start=\"1938\" data-end=\"1970\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"1940\" data-end=\"1969\"\u003e6 Neuroprotection signals\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1970\" data-end=\"2204\" data-col-size=\"xl\" style=\"width: 71.2996%;\"\u003eAR agonism with RAD-class ligands \u003cstrong data-start=\"2006\" data-end=\"2038\"\u003eprotects hippocampal neurons\u003c\/strong\u003e, enhances synaptic markers, and improves memory tasks in injury\/aging models (translational relevance pending). \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Neurobiology of Aging; Brain Research\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2205\" data-end=\"2449\"\u003e\n\u003ctd data-start=\"2205\" data-end=\"2253\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"2207\" data-end=\"2252\"\u003e7 AR-positive breast cancer (preclinical)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2253\" data-end=\"2449\" data-col-size=\"xl\" style=\"width: 71.2996%;\"\u003eIn ER⁺\/AR⁺ models, selective AR agonism \u003cstrong data-start=\"2295\" data-end=\"2321\"\u003einhibits proliferation\u003c\/strong\u003e and shows \u003cstrong data-start=\"2332\" data-end=\"2369\"\u003eadditivity with CDK4\/6 inhibitors\u003c\/strong\u003e—clinical validation needed. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Cancer Research; Annals of Oncology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2450\" data-end=\"2662\"\u003e\n\u003ctd data-start=\"2450\" data-end=\"2472\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"2452\" data-end=\"2471\"\u003e8 Rehab synergy\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2472\" data-end=\"2662\" data-col-size=\"xl\" style=\"width: 71.2996%;\"\u003ePairing with \u003cstrong data-start=\"2487\" data-end=\"2522\"\u003eprogressive resistance training\u003c\/strong\u003e yields \u003cstrong data-start=\"2530\" data-end=\"2542\"\u003eadditive\u003c\/strong\u003e hypertrophy\/function vs either alone in translational paradigms. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Sports Medicine; Journal of Physiology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2663\" data-end=\"2900\"\u003e\n\u003ctd data-start=\"2663\" data-end=\"2688\" data-col-size=\"md\" style=\"width: 28.3394%;\"\u003e\u003cstrong data-start=\"2665\" data-end=\"2687\"\u003e9 Oral convenience\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2688\" data-end=\"2900\" data-col-size=\"xl\" style=\"width: 71.2996%;\"\u003e\n\u003cstrong data-start=\"2690\" data-end=\"2709\"\u003eOnce-daily oral\u003c\/strong\u003e administration with long detection metabolites supports adherence in trials—also increases anti-doping scrutiny. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical Pharmacology \u0026amp; Therapeutics; Drug Testing \u0026amp; Analysis\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"2902\" data-end=\"2905\"\u003e\n\u003ch2 data-start=\"2907\" data-end=\"2942\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-start=\"2944\" data-end=\"2979\"\u003e2.1 Receptor Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-start=\"2980\" data-end=\"3370\"\u003eRAD-140 binds \u003cstrong data-start=\"2994\" data-end=\"3000\"\u003eAR\u003c\/strong\u003e → nuclear translocation → \u003cstrong data-start=\"3027\" data-end=\"3055\"\u003eARE-driven transcription\u003c\/strong\u003e. In muscle it \u003cstrong data-start=\"3070\" data-end=\"3102\"\u003eup-regulates mTOR\/S6K\/4E-BP1\u003c\/strong\u003e and local \u003cstrong data-start=\"3113\" data-end=\"3122\"\u003eIGF-1\u003c\/strong\u003e, while \u003cstrong data-start=\"3130\" data-end=\"3160\"\u003esuppressing FoxO-atrogenes\u003c\/strong\u003e; in bone, AR signaling promotes \u003cstrong data-start=\"3193\" data-end=\"3215\"\u003eosteoblastogenesis\u003c\/strong\u003e (Wnt\/β-catenin\/Osterix) and may indirectly restrain resorption. Lack of aromatization\/5-α reduction contributes to \u003cstrong data-start=\"3331\" data-end=\"3353\"\u003etissue selectivity\u003c\/strong\u003e vs testosterone.\u003c\/p\u003e\n\u003ch3 data-start=\"3372\" data-end=\"3399\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"3401\" data-end=\"3868\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"3401\" data-end=\"3443\"\u003e\n\u003ctr data-start=\"3401\" data-end=\"3443\"\u003e\n\u003cth data-start=\"3401\" data-end=\"3411\" data-col-size=\"sm\"\u003ePathway\u003c\/th\u003e\n\u003cth data-start=\"3411\" data-end=\"3432\" data-col-size=\"md\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-start=\"3432\" data-end=\"3443\" data-col-size=\"sm\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"3458\" data-end=\"3868\"\u003e\n\u003ctr data-start=\"3458\" data-end=\"3548\"\u003e\n\u003ctd data-start=\"3458\" data-end=\"3485\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3460\" data-end=\"3484\"\u003eAR → mTOR\/S6K\/4E-BP1\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3485\" data-end=\"3529\" data-col-size=\"md\"\u003e↑ protein synthesis, myofiber hypertrophy\u003c\/td\u003e\n\u003ctd data-start=\"3529\" data-end=\"3548\" data-col-size=\"sm\"\u003eSkeletal muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3549\" data-end=\"3621\"\u003e\n\u003ctd data-start=\"3549\" data-end=\"3582\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3551\" data-end=\"3581\"\u003eAR ↔ Wnt\/β-catenin\/Osterix\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3582\" data-end=\"3613\" data-col-size=\"md\"\u003e↑ osteoblast activity, ↑ BMD\u003c\/td\u003e\n\u003ctd data-start=\"3613\" data-end=\"3621\" data-col-size=\"sm\"\u003eBone\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3622\" data-end=\"3701\"\u003e\n\u003ctd data-start=\"3622\" data-end=\"3648\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3624\" data-end=\"3647\"\u003eFoxO → MAFbx\/MuRF1↓\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3648\" data-end=\"3681\" data-col-size=\"md\"\u003e↓ proteolysis (anti-catabolic)\u003c\/td\u003e\n\u003ctd data-start=\"3681\" data-end=\"3701\" data-col-size=\"sm\"\u003eCatabolic stress\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3702\" data-end=\"3766\"\u003e\n\u003ctd data-start=\"3702\" data-end=\"3736\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3704\" data-end=\"3735\"\u003eMyostatin\/activin crosstalk\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3736\" data-end=\"3756\" data-col-size=\"md\"\u003eNet anabolic bias\u003c\/td\u003e\n\u003ctd data-start=\"3756\" data-end=\"3766\" data-col-size=\"sm\"\u003eMuscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3767\" data-end=\"3868\"\u003e\n\u003ctd data-start=\"3767\" data-end=\"3811\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3769\" data-end=\"3810\"\u003eNeurotrophic signaling (AR-dependent)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3811\" data-end=\"3861\" data-col-size=\"md\"\u003eSynaptic support, neuroprotection (preclinical)\u003c\/td\u003e\n\u003ctd data-start=\"3861\" data-end=\"3868\" data-col-size=\"sm\"\u003eCNS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"3870\" data-end=\"3873\"\u003e\n\u003ch2 data-start=\"3875\" data-end=\"3897\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-start=\"3899\" data-end=\"4332\"\u003e\n\u003cli data-start=\"3899\" data-end=\"3919\"\u003e\n\u003cp data-start=\"3901\" data-end=\"3919\"\u003e\u003cstrong data-start=\"3901\" data-end=\"3911\"\u003eRoute:\u003c\/strong\u003e Oral.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3920\" data-end=\"4141\"\u003e\n\u003cp data-start=\"3922\" data-end=\"4141\"\u003e\u003cstrong data-start=\"3922\" data-end=\"3945\"\u003eExposure\/half-life:\u003c\/strong\u003e \u003cstrong data-start=\"3946\" data-end=\"3990\"\u003eHuman PK has not been formally published\u003c\/strong\u003e; industry\/forensic reports suggest a \u003cstrong data-start=\"4028\" data-end=\"4089\"\u003elong terminal half-life compatible with once-daily dosing\u003c\/strong\u003e and \u003cstrong data-start=\"4094\" data-end=\"4129\"\u003emulti-week metabolite detection\u003c\/strong\u003e in urine.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4142\" data-end=\"4233\"\u003e\n\u003cp data-start=\"4144\" data-end=\"4233\"\u003e\u003cstrong data-start=\"4144\" data-end=\"4159\"\u003eMetabolism:\u003c\/strong\u003e Hepatic oxidative\/conjugative clearance; \u003cstrong data-start=\"4201\" data-end=\"4221\"\u003eno aromatase\/5-α\u003c\/strong\u003e pathways.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4234\" data-end=\"4280\"\u003e\n\u003cp data-start=\"4236\" data-end=\"4280\"\u003e\u003cstrong data-start=\"4236\" data-end=\"4256\"\u003eProtein binding:\u003c\/strong\u003e High (class feature).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4281\" data-end=\"4332\"\u003e\n\u003cp data-start=\"4283\" data-end=\"4332\"\u003e\u003cstrong data-start=\"4283\" data-end=\"4299\"\u003eFood effect:\u003c\/strong\u003e Not well characterized publicly.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"4334\" data-end=\"4337\"\u003e\n\u003ch2 data-start=\"4339\" data-end=\"4384\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-start=\"4386\" data-end=\"4413\"\u003e4.1 Muscle \u0026amp; Function\u003c\/h3\u003e\n\u003cp data-start=\"4414\" data-end=\"4562\"\u003eRobust \u003cstrong data-start=\"4421\" data-end=\"4444\"\u003elean-mass and force\u003c\/strong\u003e improvements in rodent models, with \u003cstrong data-start=\"4481\" data-end=\"4511\"\u003elower prostate stimulation\u003c\/strong\u003e than testosterone for comparable anabolic effects.\u003c\/p\u003e\n\u003ch3 data-start=\"4564\" data-end=\"4578\"\u003e4.2 Bone\u003c\/h3\u003e\n\u003cp data-start=\"4579\" data-end=\"4734\"\u003eIn ovariectomized models, \u003cstrong data-start=\"4605\" data-end=\"4624\"\u003espine\/femur BMD\u003c\/strong\u003e and \u003cstrong data-start=\"4629\" data-end=\"4658\"\u003ethree-point-bend strength\u003c\/strong\u003e improve, supporting exploration as an \u003cstrong data-start=\"4697\" data-end=\"4719\"\u003eosteopenia adjunct\u003c\/strong\u003e (preclinical).\u003c\/p\u003e\n\u003ch3 data-start=\"4736\" data-end=\"4755\"\u003e4.3 Neuro\/CNS\u003c\/h3\u003e\n\u003cp data-start=\"4756\" data-end=\"4920\"\u003eAndrogen-axis agonism with RAD-class ligands shows \u003cstrong data-start=\"4807\" data-end=\"4828\"\u003eneuronal survival\u003c\/strong\u003e and \u003cstrong data-start=\"4833\" data-end=\"4856\"\u003esynaptic plasticity\u003c\/strong\u003e benefits in injury\/aging models; human translation is untested.\u003c\/p\u003e\n\u003ch3 data-start=\"4922\" data-end=\"4957\"\u003e4.4 Oncology (AR⁺\/ER⁺ breast)\u003c\/h3\u003e\n\u003cp data-start=\"4958\" data-end=\"5111\"\u003eSelective AR activation via non-steroidal ligands can \u003cstrong data-start=\"5012\" data-end=\"5047\"\u003einhibit ER-driven proliferation\u003c\/strong\u003e in preclinical systems; RAD-140 is part of this research space.\u003c\/p\u003e\n\u003cblockquote data-start=\"5113\" data-end=\"5325\"\u003e\n\u003cp data-start=\"5115\" data-end=\"5325\"\u003e\u003cstrong data-start=\"5115\" data-end=\"5141\"\u003eEvidence quality note:\u003c\/strong\u003e For RAD-140 specifically, \u003cstrong data-start=\"5168\" data-end=\"5209\"\u003ehuman efficacy\/safety data are sparse\u003c\/strong\u003e. Most signals derive from \u003cstrong data-start=\"5236\" data-end=\"5255\"\u003eanimal\/in-vitro\u003c\/strong\u003e work and \u003cstrong data-start=\"5265\" data-end=\"5290\"\u003eanti-doping forensics\u003c\/strong\u003e rather than registrational trials.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-start=\"5327\" data-end=\"5330\"\u003e\n\u003ch2 data-start=\"5332\" data-end=\"5365\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"5367\" data-end=\"5908\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"5367\" data-end=\"5405\"\u003e\n\u003ctr data-start=\"5367\" data-end=\"5405\"\u003e\n\u003cth data-start=\"5367\" data-end=\"5375\" data-col-size=\"sm\"\u003eField\u003c\/th\u003e\n\u003cth data-start=\"5375\" data-end=\"5387\" data-col-size=\"md\"\u003eRationale\u003c\/th\u003e\n\u003cth data-start=\"5387\" data-end=\"5405\" data-col-size=\"sm\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"5420\" data-end=\"5908\"\u003e\n\u003ctr data-start=\"5420\" data-end=\"5525\"\u003e\n\u003ctd data-start=\"5420\" data-end=\"5445\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5422\" data-end=\"5444\"\u003eSarcopenia\/frailty\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5445\" data-end=\"5490\" data-col-size=\"md\"\u003eOral anabolic with prostate-sparing intent\u003c\/td\u003e\n\u003ctd data-start=\"5490\" data-end=\"5525\" data-col-size=\"sm\"\u003ePreclinical\/early translational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5526\" data-end=\"5614\"\u003e\n\u003ctd data-start=\"5526\" data-end=\"5562\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5528\" data-end=\"5561\"\u003eRehabilitation\/immobilization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5562\" data-end=\"5596\" data-col-size=\"md\"\u003ePreserve\/restore FFM \u0026amp; function\u003c\/td\u003e\n\u003ctd data-start=\"5596\" data-end=\"5614\" data-col-size=\"sm\"\u003eConcept pilots\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5615\" data-end=\"5712\"\u003e\n\u003ctd data-start=\"5615\" data-end=\"5655\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5617\" data-end=\"5654\"\u003eOsteopenia\/osteoporosis (adjunct)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5655\" data-end=\"5697\" data-col-size=\"md\"\u003eBone-anabolic + anti-resorptive balance\u003c\/td\u003e\n\u003ctd data-start=\"5697\" data-end=\"5712\" data-col-size=\"sm\"\u003ePreclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5713\" data-end=\"5792\"\u003e\n\u003ctd data-start=\"5713\" data-end=\"5728\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5715\" data-end=\"5727\"\u003eCachexia\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5728\" data-end=\"5777\" data-col-size=\"md\"\u003eAppetite-neutral anabolism vs ghrelin mimetics\u003c\/td\u003e\n\u003ctd data-start=\"5777\" data-end=\"5792\" data-col-size=\"sm\"\u003ePreclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5793\" data-end=\"5908\"\u003e\n\u003ctd data-start=\"5793\" data-end=\"5821\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"5795\" data-end=\"5820\"\u003eAR⁺\/ER⁺ breast cancer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"5821\" data-end=\"5866\" data-col-size=\"md\"\u003eSelective AR agonism as antitumor strategy\u003c\/td\u003e\n\u003ctd data-start=\"5866\" data-end=\"5908\" data-col-size=\"sm\"\u003ePreclinical\/early clinical exploration\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"5910\" data-end=\"5913\"\u003e\n\u003ch2 data-start=\"5915\" data-end=\"5944\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-start=\"5946\" data-end=\"6875\"\u003e\n\u003cli data-start=\"5946\" data-end=\"6087\"\u003e\n\u003cp data-start=\"5948\" data-end=\"6087\"\u003e\u003cstrong data-start=\"5948\" data-end=\"5962\"\u003eEndocrine:\u003c\/strong\u003e \u003cstrong data-start=\"5963\" data-end=\"6002\"\u003eDose-dependent HPG-axis suppression\u003c\/strong\u003e (↓ LH\/FSH\/testosterone) expected; recovery often \u003cstrong data-start=\"6052\" data-end=\"6068\"\u003eweeks–months\u003c\/strong\u003e after cessation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6088\" data-end=\"6173\"\u003e\n\u003cp data-start=\"6090\" data-end=\"6173\"\u003e\u003cstrong data-start=\"6090\" data-end=\"6101\"\u003eLipids:\u003c\/strong\u003e \u003cstrong data-start=\"6102\" data-end=\"6121\"\u003eHDL-C reduction\u003c\/strong\u003e (± ↑ LDL\/TG) common across SARMs—monitor CV risk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6174\" data-end=\"6371\"\u003e\n\u003cp data-start=\"6176\" data-end=\"6371\"\u003e\u003cstrong data-start=\"6176\" data-end=\"6188\"\u003eHepatic:\u003c\/strong\u003e Short controlled datasets are limited; \u003cstrong data-start=\"6228\" data-end=\"6285\"\u003ecase reports of cholestatic\/drug-induced liver injury\u003c\/strong\u003e exist with unregulated RAD-140–containing products (purity\/co-ingestants confound).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6372\" data-end=\"6454\"\u003e\n\u003cp data-start=\"6374\" data-end=\"6454\"\u003e\u003cstrong data-start=\"6374\" data-end=\"6381\"\u003eCV:\u003c\/strong\u003e No outcome data; lipid shifts and possible BP effects warrant caution.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6455\" data-end=\"6553\"\u003e\n\u003cp data-start=\"6457\" data-end=\"6553\"\u003e\u003cstrong data-start=\"6457\" data-end=\"6485\"\u003eDermatologic\/androgenic:\u003c\/strong\u003e \u003cstrong data-start=\"6486\" data-end=\"6504\"\u003eAcne\/oily skin\u003c\/strong\u003e, \u003cstrong data-start=\"6506\" data-end=\"6523\"\u003ehair shedding\u003c\/strong\u003e in predisposed individuals.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6554\" data-end=\"6658\"\u003e\n\u003cp data-start=\"6556\" data-end=\"6658\"\u003e\u003cstrong data-start=\"6556\" data-end=\"6571\"\u003eNeuropsych:\u003c\/strong\u003e \u003cstrong data-start=\"6572\" data-end=\"6607\"\u003eInsomnia, irritability, anxiety\u003c\/strong\u003e occasionally described in uncontrolled settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6659\" data-end=\"6742\"\u003e\n\u003cp data-start=\"6661\" data-end=\"6742\"\u003e\u003cstrong data-start=\"6661\" data-end=\"6677\"\u003eHematologic:\u003c\/strong\u003e \u003cstrong data-start=\"6678\" data-end=\"6699\"\u003eMild ↑ hematocrit\u003c\/strong\u003e possible—monitor in at-risk populations.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6743\" data-end=\"6875\"\u003e\n\u003cp data-start=\"6745\" data-end=\"6875\"\u003e\u003cstrong data-start=\"6745\" data-end=\"6767\"\u003eDrug interactions:\u003c\/strong\u003e Potential with drugs affecting \u003cstrong data-start=\"6799\" data-end=\"6825\"\u003ehepatic enzymes\/lipids\u003c\/strong\u003e; avoid \u003cstrong data-start=\"6833\" data-end=\"6849\"\u003ehepatotoxins\u003c\/strong\u003e and \u003cstrong data-start=\"6854\" data-end=\"6874\"\u003euse in pregnancy\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"6877\" data-end=\"6906\"\u003e\u003cstrong data-start=\"6877\" data-end=\"6906\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"6908\" data-end=\"7415\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"6908\" data-end=\"6974\"\u003e\n\u003ctr data-start=\"6908\" data-end=\"6974\"\u003e\n\u003cth data-start=\"6908\" data-end=\"6918\" data-col-size=\"sm\"\u003eConcern\u003c\/th\u003e\n\u003cth data-start=\"6918\" data-end=\"6932\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6920\" data-end=\"6931\"\u003eRAD-140\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"6932\" data-end=\"6947\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6934\" data-end=\"6946\"\u003eLGD-4033\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"6947\" data-end=\"6974\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6949\" data-end=\"6972\"\u003eEnobosarm (MK-2866)\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"6993\" data-end=\"7415\"\u003e\n\u003ctr data-start=\"6993\" data-end=\"7068\"\u003e\n\u003ctd data-start=\"6993\" data-end=\"7010\" data-col-size=\"sm\"\u003eHuman evidence\u003c\/td\u003e\n\u003ctd data-start=\"7010\" data-end=\"7029\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7012\" data-end=\"7028\"\u003eVery limited\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7029\" data-end=\"7048\" data-col-size=\"sm\"\u003eSmall RCT (21 d)\u003c\/td\u003e\n\u003ctd data-start=\"7048\" data-end=\"7068\" data-col-size=\"sm\"\u003eMultiple Phase 2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7069\" data-end=\"7132\"\u003e\n\u003ctd data-start=\"7069\" data-end=\"7087\" data-col-size=\"sm\"\u003eHPG suppression\u003c\/td\u003e\n\u003ctd data-start=\"7087\" data-end=\"7109\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7089\" data-end=\"7108\"\u003eModerate–strong\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7109\" data-end=\"7120\" data-col-size=\"sm\"\u003eModerate\u003c\/td\u003e\n\u003ctd data-start=\"7120\" data-end=\"7132\" data-col-size=\"sm\"\u003eModerate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7133\" data-end=\"7184\"\u003e\n\u003ctd data-start=\"7133\" data-end=\"7146\" data-col-size=\"sm\"\u003eHDL impact\u003c\/td\u003e\n\u003ctd data-start=\"7146\" data-end=\"7161\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7148\" data-end=\"7160\"\u003e↓ Common\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7161\" data-end=\"7172\" data-col-size=\"sm\"\u003e↓ Common\u003c\/td\u003e\n\u003ctd data-start=\"7172\" data-end=\"7184\" data-col-size=\"sm\"\u003e↓ Common\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7185\" data-end=\"7245\"\u003e\n\u003ctd data-start=\"7185\" data-end=\"7208\" data-col-size=\"sm\"\u003eProstate stimulation\u003c\/td\u003e\n\u003ctd data-start=\"7208\" data-end=\"7232\" data-col-size=\"sm\"\u003e\n\u003cstrong data-start=\"7210\" data-end=\"7217\"\u003eLow\u003c\/strong\u003e (preclinical)\u003c\/td\u003e\n\u003ctd data-start=\"7232\" data-end=\"7238\" data-col-size=\"sm\"\u003eLow\u003c\/td\u003e\n\u003ctd data-start=\"7238\" data-end=\"7245\" data-col-size=\"sm\"\u003eLow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7246\" data-end=\"7342\"\u003e\n\u003ctd data-start=\"7246\" data-end=\"7270\" data-col-size=\"sm\"\u003eHepatotoxicity signal\u003c\/td\u003e\n\u003ctd data-start=\"7270\" data-end=\"7303\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7272\" data-end=\"7302\"\u003eCase reports (unregulated)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7303\" data-end=\"7318\" data-col-size=\"sm\"\u003eCase reports\u003c\/td\u003e\n\u003ctd data-start=\"7318\" data-end=\"7342\" data-col-size=\"sm\"\u003eCase reports (rarer)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7343\" data-end=\"7415\"\u003e\n\u003ctd data-start=\"7343\" data-end=\"7356\" data-col-size=\"sm\"\u003eRoute \/ t½\u003c\/td\u003e\n\u003ctd data-start=\"7356\" data-end=\"7384\" data-col-size=\"sm\"\u003eOral; \u003cstrong data-start=\"7364\" data-end=\"7372\"\u003elong\u003c\/strong\u003e (inferred)\u003c\/td\u003e\n\u003ctd data-start=\"7384\" data-end=\"7400\" data-col-size=\"sm\"\u003eOral; 24–36 h\u003c\/td\u003e\n\u003ctd data-start=\"7400\" data-end=\"7415\" data-col-size=\"sm\"\u003eOral; ~24 h\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"7417\" data-end=\"7420\"\u003e\n\u003ch2 data-start=\"7422\" data-end=\"7448\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-start=\"7450\" data-end=\"7784\"\u003e\n\u003cli data-start=\"7450\" data-end=\"7505\"\u003e\n\u003cp data-start=\"7452\" data-end=\"7505\"\u003e\u003cstrong data-start=\"7452\" data-end=\"7466\"\u003eApprovals:\u003c\/strong\u003e \u003cstrong data-start=\"7467\" data-end=\"7475\"\u003eNone\u003c\/strong\u003e for any medical indication.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7506\" data-end=\"7653\"\u003e\n\u003cp data-start=\"7508\" data-end=\"7653\"\u003e\u003cstrong data-start=\"7508\" data-end=\"7518\"\u003eSport:\u003c\/strong\u003e \u003cstrong data-start=\"7519\" data-end=\"7538\"\u003eWADA-prohibited\u003c\/strong\u003e (S1, Other Anabolic Agents) at all times; detection of \u003cstrong data-start=\"7594\" data-end=\"7619\"\u003elong-term metabolites\u003c\/strong\u003e enables \u003cstrong data-start=\"7628\" data-end=\"7642\"\u003eweeks-long\u003c\/strong\u003e windows.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7654\" data-end=\"7784\"\u003e\n\u003cp data-start=\"7656\" data-end=\"7784\"\u003e\u003cstrong data-start=\"7656\" data-end=\"7675\"\u003eMarket quality:\u003c\/strong\u003e Grey-market products frequently show \u003cstrong data-start=\"7713\" data-end=\"7741\"\u003eadulteration\/mislabeling\u003c\/strong\u003e; medical use outside trials is \u003cstrong data-start=\"7773\" data-end=\"7783\"\u003eunsafe\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"7786\" data-end=\"7789\"\u003e\n\u003ch2 data-start=\"7791\" data-end=\"7814\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-start=\"7816\" data-end=\"8553\"\u003e\n\u003cli data-start=\"7816\" data-end=\"7923\"\u003e\n\u003cp data-start=\"7818\" data-end=\"7923\"\u003e\u003cstrong data-start=\"7818\" data-end=\"7842\"\u003eFirst-in-human PK\/PD\u003c\/strong\u003e with \u003cstrong data-start=\"7848\" data-end=\"7855\"\u003eGMP\u003c\/strong\u003e material to define \u003cstrong data-start=\"7875\" data-end=\"7920\"\u003ehalf-life, metabolites, exposure–response\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7924\" data-end=\"8041\"\u003e\n\u003cp data-start=\"7926\" data-end=\"8041\"\u003e\u003cstrong data-start=\"7926\" data-end=\"7942\"\u003eHead-to-head\u003c\/strong\u003e vs other SARMs for \u003cstrong data-start=\"7962\" data-end=\"7991\"\u003eanabolic:androgenic ratio\u003c\/strong\u003e, \u003cstrong data-start=\"7993\" data-end=\"8013\"\u003elipid neutrality\u003c\/strong\u003e, and \u003cstrong data-start=\"8019\" data-end=\"8038\"\u003eHPG suppression\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8042\" data-end=\"8150\"\u003e\n\u003cp data-start=\"8044\" data-end=\"8150\"\u003e\u003cstrong data-start=\"8044\" data-end=\"8064\"\u003eLong-term safety\u003c\/strong\u003e: lipids\/CV outcomes, \u003cstrong data-start=\"8086\" data-end=\"8097\"\u003ehepatic\u003c\/strong\u003e profile, \u003cstrong data-start=\"8107\" data-end=\"8129\"\u003eendocrine recovery\u003c\/strong\u003e, mood\/CNS effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8151\" data-end=\"8266\"\u003e\n\u003cp data-start=\"8153\" data-end=\"8266\"\u003e\u003cstrong data-start=\"8153\" data-end=\"8174\"\u003eOncology programs\u003c\/strong\u003e in \u003cstrong data-start=\"8178\" data-end=\"8203\"\u003eAR⁺\/ER⁺ breast cancer\u003c\/strong\u003e, rational \u003cstrong data-start=\"8214\" data-end=\"8263\"\u003ecombos (CDK4\/6 inhibitors, endocrine therapy)\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8267\" data-end=\"8436\"\u003e\n\u003cp data-start=\"8269\" data-end=\"8436\"\u003e\u003cstrong data-start=\"8269\" data-end=\"8294\"\u003eRehab\/sarcopenia RCTs\u003c\/strong\u003e paired with \u003cstrong data-start=\"8307\" data-end=\"8342\"\u003eprogressive resistance training\u003c\/strong\u003e and \u003cstrong data-start=\"8347\" data-end=\"8366\"\u003eprotein targets\u003c\/strong\u003e; standardized functional endpoints (SPPB, stair-climb power, 6MWT).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8437\" data-end=\"8553\"\u003e\n\u003cp data-start=\"8439\" data-end=\"8553\"\u003e\u003cstrong data-start=\"8439\" data-end=\"8458\"\u003eDoping science:\u003c\/strong\u003e Comprehensive \u003cstrong data-start=\"8473\" data-end=\"8490\"\u003emetabolite ID\u003c\/strong\u003e, hair\/urine detection windows, and contamination risk mapping.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"8555\" data-end=\"8558\"\u003e\n\u003ch3 data-start=\"8560\" data-end=\"8583\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-start=\"8585\" data-end=\"9532\"\u003e\n\u003cli data-start=\"8585\" data-end=\"8729\"\u003e\n\u003cp data-start=\"8587\" data-end=\"8729\"\u003e\u003cstrong data-start=\"8587\" data-end=\"8657\"\u003eJournal of Pharmacology \u0026amp; Experimental Therapeutics; FASEB Journal\u003c\/strong\u003e — Anabolic and anti-catabolic signaling of RAD-class SARMs in muscle.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8730\" data-end=\"8851\"\u003e\n\u003cp data-start=\"8732\" data-end=\"8851\"\u003e\u003cstrong data-start=\"8732\" data-end=\"8778\"\u003eJournal of Bone and Mineral Research; Bone\u003c\/strong\u003e — SARM effects on BMD and biomechanical strength in osteopenic models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8852\" data-end=\"8963\"\u003e\n\u003cp data-start=\"8854\" data-end=\"8963\"\u003e\u003cstrong data-start=\"8854\" data-end=\"8895\"\u003eNeurobiology of Aging; Brain Research\u003c\/strong\u003e — AR-mediated neuroprotection and synaptic support (preclinical).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8964\" data-end=\"9063\"\u003e\n\u003cp data-start=\"8966\" data-end=\"9063\"\u003e\u003cstrong data-start=\"8966\" data-end=\"9005\"\u003eCancer Research; Annals of Oncology\u003c\/strong\u003e — Selective AR agonism in ER⁺\/AR⁺ breast cancer models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9064\" data-end=\"9182\"\u003e\n\u003cp data-start=\"9066\" data-end=\"9182\"\u003e\u003cstrong data-start=\"9066\" data-end=\"9128\"\u003eMedicine \u0026amp; Science in Sports \u0026amp; Exercise; AJP–Endocrinology\u003c\/strong\u003e — Strength\/function correlates under AR activation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9183\" data-end=\"9287\"\u003e\n\u003cp data-start=\"9185\" data-end=\"9287\"\u003e\u003cstrong data-start=\"9185\" data-end=\"9212\"\u003eDrug Testing \u0026amp; Analysis\u003c\/strong\u003e — Identification of RAD-140 long-term metabolites and detection windows.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9288\" data-end=\"9434\"\u003e\n\u003cp data-start=\"9290\" data-end=\"9434\"\u003e\u003cstrong data-start=\"9290\" data-end=\"9342\"\u003eHepatology Communications; J Clin Transl Hepatol\u003c\/strong\u003e — Case reports of liver injury associated with unregulated SARM products (class context).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9435\" data-end=\"9532\"\u003e\n\u003cp data-start=\"9437\" data-end=\"9532\"\u003e\u003cstrong data-start=\"9437\" data-end=\"9477\"\u003eClinical Pharmacology \u0026amp; Therapeutics\u003c\/strong\u003e — Oral PK\/PD considerations for non-steroidal SARMs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684858523986,"sku":"10","price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/rad140_1g.png?v=1770834888","url":"https:\/\/sciencepeptideslab.com\/products\/rad140-1gr","provider":"Science Peptides Lab","version":"1.0","type":"link"}